Piper Sandler upgraded Guardant Health to Overweight from Neutral with an unchanged price target of $40.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GH:
- Guardant Health receives coverage for Guardant Reveal from Geisinger
- Guardant Health receives regulatory approval in Japan Guardant360 CDx
- Guardant Health agrees decision to close COBRA study to new enrollees
- Guardant Health price target raised to $40 from $30 at Piper Sandler
- Guardant Health price target raised to $50 from $40 at Citi